Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Julphar
Chubb
US Army
McKesson
UBS
Fish and Richardson
Covington
AstraZeneca

Generated: August 21, 2018

DrugPatentWatch Database Preview

CEFAZOLIN SODIUM Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Cefazolin Sodium, and when can generic versions of Cefazolin Sodium launch?

Cefazolin Sodium is a drug marketed by Abraxis Pharm, Acs Dobfar, Aurobindo Pharma, Bedford, Cephazone Pharma, Facta Farma, Fresenius Kabi Usa, Glaxosmithkline, Hikma Farmaceutica, Hospira Inc, Qilu Pharm Co Ltd, Samson Medcl, Sandoz, Steri Pharma, Teva Pharms, Watson Labs Inc, and West-ward Pharms Int. and is included in thirty-one NDAs.

The generic ingredient in CEFAZOLIN SODIUM is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.

Drug patent expirations by year for CEFAZOLIN SODIUM
Pharmacology for CEFAZOLIN SODIUM
Medical Subject Heading (MeSH) Categories for CEFAZOLIN SODIUM
Synonyms for CEFAZOLIN SODIUM
27164-46-1
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-, (6R-trans)-, sodium salt
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-, monosodium salt (6R-trans)-
AC-13166
AK326218
AKOS015895533
Ancef
Ancef (TN)
ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER
ANCEF IN PLASTIC CONTAINER
ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AS-12230
Atirin
Biazolina
Bor-Cefazol
C 5020
C-44235
C08098
C14H13N8NaO4S3
CCG-40011
Cefabiozim
Cefacidal
Cefalomicina
Cefamedin
Cefazil
Cefazina
Cefazolin (sodium)
CEFAZOLIN AND DEXTROSE
Cefazolin sodium (JP17/USP)
Cefazolin sodium [USAN:USP:JAN]
Cefazolin sodium salt
Cefazolin sodium salt, 89.1-110.1%
Cefazolin sodium salt, Antibiotic for Culture Media Use Only
Cefazoline sodium
CEZ sodium
CHEBI:3483
CHEMBL1200523
CS-4634
D00905
EINECS 248-278-4
EU-0100274
Firmacef
FLKYBGKDCCEQQM-WYUVZMMLSA-M
Gramaxin
HMS1570C14
HMS1920K07
HMS2091A10
HMS2097C14
HMS2230I22
HMS3260H10
HMS500A16
HY-B1078
I06-1090
Kefzol
KS-00000FVS
Lampocef
Lilly 46083
Liviclina
LP00274
MCULE-2075772357
MFCD00056883
MLS000028706
MolPort-002-510-626
Monosodium (6R,7R)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
Monosodium cefazolin
NCGC00093731-01
NCGC00260959-01
Neofazol
NSC 291561
Opera_ID_1323
P380M0454Z
Prestwick_975
Recef
s4595
SCHEMBL40735
SK&F 41558
SK&F-41558
SKF 41558
SMR000058708
Sodium (6R-trans)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(1H-tetrazol-1-ylacetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
Sodium (6R,7R)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
sodium (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Sodium (6R,7R)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylate
sodium 7beta-(1H-tetrazol-1-yl)acetamido-3-(2-methyl-1,3,4-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylate
sodium 7beta-[2-(1H-tetrazol-1-yl)-acetamido]-3-(2-methyl-1,3,4-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylate
sodium 7beta-[2-(1H-tetrazol-1-yl)acetamido]-3-(2-methyl-1,3,4-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylate
Sodium cefazolin
sodium cefazolin(1-)
Sodium cephazolin
Sodium CEZ
Sodium CEZ; SKF-41558
sodium;(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
SPECTRUM1500164
ST024775
STOCK1N-08270
Totacef
Tox21_500274
UNII-P380M0454Z
Zolicef
Zolin
Zolisint
ZX-AFC000519

US Patents and Regulatory Information for CEFAZOLIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 065345-001 May 9, 2007 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira Inc CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 065226-002 Apr 21, 2005 AP RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharms CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 063016-001 Mar 14, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 062807-006 Jan 12, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Steri Pharma CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 063216-001 Dec 27, 1991 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
AstraZeneca
Teva
Chinese Patent Office
US Department of Justice
Harvard Business School
Mallinckrodt
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.